Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of its novel Quality Assessment Products ("QAPs™") and platform technology for supporting the quality management and reproducibility of […]
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against BellRing Brands, Inc. (NYSE:BRBR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Smartsheet Inc. ("Smartsheet" or the "Company") (NYSE:SMAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
Emerging biotechs and top biopharmas trust Link to power customer engagement and provide structured datasets to fuel AI initiatives Veeva Systems (NYSE: VEEV) today announced that 13 of the top 20 biopharmas have standardized on Veeva Link Key People to enhance customer engagement and provide data for AI globally. Biopharmas of all sizes use Link
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation ("Integer" or the "Company") (NYSE:ITGR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ:VRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Varonis Systems, Inc. (NASDAQ:VRNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the
Nationally Recognized Firm Urges GAUZ Investors to Explore Class Action Representationâ?¯ NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Gauzy Ltd. ("Gauzy" or "the Company") (NASDAQ:GAUZ) and certain of its